Epithelial ovarian cancer: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
|- | |- | ||
| | | | ||
* Breast cancer (male and female) | |||
* Ovarian cancer | |||
* Fallopian tube carcinoma | |||
* Primary papillary carcinoma of the peritoneum | |||
* Prostate cancer | |||
* Uterine body cancer | |||
* Cervical cancer | |||
* Pancreatic cancer | |||
* Gall bladder cancer | |||
* Bile duct cancer | |||
* Stomach cancer | |||
* Melanoma | |||
* | * | ||
|} | |} | ||
{{Epithelial ovarian cancer}} | {{Epithelial ovarian cancer}} | ||
{{CMG}}{{AE}}{{HMHJ}} | {{CMG}}{{AE}}{{HMHJ}} | ||
Revision as of 18:24, 25 February 2019
| Malignancies associated with BRCA mutations (Hereditary breast and ovarian cancer syndrome) |
|---|
|
Template:Epithelial ovarian cancer Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]